000166534 001__ 166534
000166534 005__ 20240229133523.0
000166534 0247_ $$2doi$$a10.1111/nan.12680
000166534 0247_ $$2pmid$$apmid:33325069
000166534 0247_ $$2ISSN$$a0305-1846
000166534 0247_ $$2ISSN$$a1365-2990
000166534 0247_ $$2altmetric$$aaltmetric:96099895
000166534 037__ $$aDKFZ-2020-02977
000166534 041__ $$aeng
000166534 082__ $$a610
000166534 1001_ $$00000-0001-7888-1723$$aPickles, Jessica C$$b0
000166534 245__ $$aA case series of Diffuse Glioneuronal Tumours with Oligodendroglioma-like features and Nuclear Clusters (DGONC).
000166534 260__ $$aOxford [u.a.]$$bWiley-Blackwell$$c2021
000166534 3367_ $$2DRIVER$$aarticle
000166534 3367_ $$2DataCite$$aOutput Types/Journal article
000166534 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1655811975_29661
000166534 3367_ $$2BibTeX$$aARTICLE
000166534 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000166534 3367_ $$00$$2EndNote$$aJournal Article
000166534 500__ $$a2021 Apr;47(3):464-467
000166534 520__ $$aWe read with interest Deng et al.'s recent manuscript concerning a newly molecularly defined glioneuronal CNS tumour entity, termed diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC)(1). DGONCs were identified by a distinctive methylation profile that segregated away from previously recognised molecular groups of CNS tumours. On further review, the authors describe DGONCs as a novel glioneuronal tumour with key neuropathological features including oligodendroglioma-like perinuclear halos and nuclear clusters.
000166534 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000166534 588__ $$aDataset connected to CrossRef, PubMed,
000166534 650_7 $$2Other$$aDNA methylation classification
000166534 650_7 $$2Other$$abrain tumour
000166534 650_7 $$2Other$$aglioneuronal tumour
000166534 650_7 $$2Other$$amonosomy 14
000166534 650_7 $$2Other$$apaediatric
000166534 7001_ $$aMankad, Kshitij$$b1
000166534 7001_ $$aAizpurua, Miren$$b2
000166534 7001_ $$aPaine, Simon Ml$$b3
000166534 7001_ $$aBridges, Leslie R$$b4
000166534 7001_ $$00000-0003-3094-3758$$aCarceller, Fernando$$b5
000166534 7001_ $$aSzychot, Elwira$$b6
000166534 7001_ $$aWalker, Mark$$b7
000166534 7001_ $$aFairchild, Amy R$$b8
000166534 7001_ $$aMistry, Talisa$$b9
000166534 7001_ $$aOgunbiyi, Olumide$$b10
000166534 7001_ $$aRolland, Alice$$b11
000166534 7001_ $$aStone, Thomas J$$b12
000166534 7001_ $$aDryden, Carryl$$b13
000166534 7001_ $$aAddy, Dilys$$b14
000166534 7001_ $$aGarimberti, Elisa$$b15
000166534 7001_ $$aChalker, Jane$$b16
000166534 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b17$$udkfz
000166534 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b18$$udkfz
000166534 7001_ $$aHargrave, Darren$$b19
000166534 7001_ $$00000-0002-7833-2158$$aJacques, Thomas S$$b20
000166534 773__ $$0PERI:(DE-600)2008293-9$$a10.1111/nan.12680$$gp. nan.12680$$n3$$p464-467$$tNeuropathology & applied neurobiology$$v47$$x1365-2990$$y2021
000166534 909CO $$ooai:inrepo02.dkfz.de:166534$$pVDB
000166534 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000166534 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000166534 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000166534 9130_ $$0G:(DE-HGF)POF3-319H$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vAddenda$$x0
000166534 9141_ $$y2021
000166534 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2020-08-20$$wger
000166534 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROPATH APPL NEURO : 2018$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-08-20
000166534 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROPATH APPL NEURO : 2018$$d2020-08-20
000166534 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x0
000166534 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x1
000166534 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x2
000166534 980__ $$ajournal
000166534 980__ $$aVDB
000166534 980__ $$aI:(DE-He78)HD01-20160331
000166534 980__ $$aI:(DE-He78)B300-20160331
000166534 980__ $$aI:(DE-He78)B360-20160331
000166534 980__ $$aUNRESTRICTED